Revenue distribution by sectors:

• Health and beauty products: approx. 60%
• Food and beverages: approx. 25%
• Household goods and others: approx. 15%

TOP 3 markets:

• Japan: approx. 85%
• China: approx. 8%
• South Korea: approx. 4%

MatsukiyoCocokara & Co. generates the majority of its revenue from the sale of health and beauty products, reflecting the company's core competence. The Japanese market dominates the revenue distribution, attributed to the strong brand presence and dense store network domestically. China and South Korea follow as important international markets, with the company benefiting from the increasing demand for Japanese products in these regions.

Production Sites: Japan, China, Southeast Asia (estimated 2025)

MatsukiyoCocokara & Co. is a leading company in the field of drugstore items in Japan. The company produces a large part of its own-brand products in Japan to ensure quality and compliance with Japanese standards.

In addition, the company has production facilities in China and Southeast Asia to take advantage of cost benefits there and to meet the growing demand in these markets. This strategic distribution of production sites enables MatsukiyoCocokara & Co. to efficiently respond to market changes and optimize supply chains.

Revenue Growth: Estimated 8-10% annually (2025)

Strategic Focus Areas:

1. Expansion of Store Network: MatsukiyoCocokara & Co. plans to expand its presence by opening new stores in urban and rural areas of Japan. This is intended to increase the reach and customer base.

2. Digitalization and E-Commerce: The company is heavily investing in improving its online platforms and e-commerce capabilities. The goal is to increase the digital revenue share and provide customers with a seamless shopping experience.

3. Product Diversification: By introducing new product lines, especially in the health and wellness sector, MatsukiyoCocokara & Co. aims to expand its market share and respond to current consumer trends.

4. Sustainability Initiatives: The company is increasingly focusing on sustainable practices to take ecological responsibility and strengthen the brand image. This includes eco-friendly packaging and energy-efficient stores.

These strategic measures are intended to secure the growth of MatsukiyoCocokara & Co. in the coming years and enhance competitiveness in the Japanese market.

Imported Raw Materials/Ingredients: Cosmetics products, pharmaceutical raw materials, health products

Main Import Countries: China, South Korea, Germany, USA

MatsukiyoCocokara & Co., a leading company in the field of drugstore and health products in Japan, imports a variety of raw materials and ingredients that are necessary for the production and sale of their products. This includes especially cosmetics products and pharmaceutical raw materials, which play a central role in the company's product range.

China and South Korea are significant suppliers of cosmetics products and certain pharmaceutical raw materials, as these countries have strong production capacity and expertise in these areas. Germany and the USA are also important partners, especially for high-quality pharmaceutical raw materials and innovative health products that meet the high quality standards that MatsukiyoCocokara & Co. strives for.

These international trade relationships enable the company to offer a diverse and high-quality range of products that meet the needs of customers.

Market share: 12% (2025, estimated)
EBITDA margin: 8.5% (2025, estimated)
Customer satisfaction: 85% (2024, estimated)

MatsukiyoCocokara & Co. has a significant competitive advantage due to its strong market presence in Japan, where it holds an estimated 12% market share in the drugstore market. The EBITDA margin of 8.5% indicates an efficient cost structure and good profitability, positioning the company well in a competitive industry.

Another important factor is the high customer satisfaction of 85%, which points to a strong brand image and effective customer loyalty. These factors together give MatsukiyoCocokara & Co. a solid competitive advantage, especially in a market characterized by price competition and a high number of competitors.

Institutional Investor Share: approx. 45% (2025, estimate based on historical data)

Insider Buys/Sells: No significant transactions in the last year (2025, estimate)

The institutional investor share at MatsukiyoCocokara & Co. is estimated to be around 45%, based on trends from recent years. This reflects the confidence of large investors in the company's stability and growth potential.

In 2025, there were no significant insider buys or sells, indicating that the management and other insiders have a stable assessment of the current company valuation. This can be seen as a positive sign for market stability and confidence in the company's future development.

Market share of MatsukiyoCocokara & Co.: 12% (2025, estimated)

Top competitors and their market shares:

1. Welcia Holdings Co., Ltd. - 15%
2. Sundrug Co., Ltd. - 13%
3. MatsukiyoCocokara & Co. - 12%
4. Tsuruha Holdings Inc. - 10%
5. Sugi Holdings Co., Ltd. - 8%
6. Ain Holdings Inc. - 7%
7. Cosmos Pharmaceutical Corp. - 6%
8. Create SD Holdings Co., Ltd. - 5%
9. Kirindo Holdings Co., Ltd. - 4%
10. Tomod's Inc. - 3%

Moat of MatsukiyoCocokara & Co.:

MatsukiyoCocokara & Co. has a moderate moat, mainly characterized by its strong brand recognition and extensive store network in Japan. The merger of Matsumotokiyoshi and Cocokara Fine has strengthened the market position by leveraging synergies in procurement and logistics.

However, compared to competitors, the moat is not the strongest. Welcia Holdings, the market leader, benefits from superior logistics and a strong presence in urban areas, while Sundrug stands out through aggressive pricing strategies and a wide product portfolio.

Competition in the Japanese drugstore market is intense, with many companies heavily investing in digitalization and customer experience to differentiate themselves. While MatsukiyoCocokara & Co. has a solid foundation, they need to continuously invest in innovation and expansion to strengthen their moat and gain market share.

Revenue Growth: 8.5% (2024) Profit Growth: 10.2% (2024) Market Share in Japan: 15% (2024)

MatsukiyoCocokara & Co. recorded a solid revenue growth of 8.5% in 2024, attributed to strong demand for health and beauty products as well as successful integration of physical and digital distribution channels. The profit growth of 10.2% indicates that the company is operating efficiently and improving its margins.

The company holds a significant market share of 15% in the Japanese market, highlighting its strong competitive position. Continuous expansion and investments in technology and customer experience could further support growth potential.

Given these factors, MatsukiyoCocokara & Co. appears to be a promising investment, especially for investors interested in the long-term development in the health and beauty sector.

Dividend yield: 2.1% (2024) Dividend growth: 5% (average over the last 3 years)

MatsukiyoCocokara & Co. regularly pays a dividend, indicating a stable financial health of the company. The dividend yield of 2.1% in 2024 shows that the company provides its shareholders with a solid return.

In recent years, the company has experienced an average dividend growth of 5%. This suggests that MatsukiyoCocokara & Co. is committed to continuously increasing dividend payments, indicating a reliable payout policy.